|
Ketoconazole
(kee'' toe kon' a zole).
DEFINITION
Ketoconazole contains NLT 98.0% and NMT 102.0% of ketoconazole (C26H28Cl2N4O4), calculated on the dried basis.
IDENTIFICATION
Add the following:
• ASSAY
Change to read:
• Procedure
Solution A:
Solution B:
Mobile phase:
Table 1
Diluent:
Standard solution:
Sample solution:
Chromatographic system
Mode:
Detector:
Column:
Flow rate:
Injection volume:
System suitability
Sample:
Suitability requirements
Tailing factor:
Relative standard deviation:
Analysis
Samples:
Calculate the percentage of ketoconazole (C26H28Cl2N4O4) in the portion of Ketoconazole taken:
Result = (rU/rS) × (CS/CU) × 100
Acceptance criteria:
IMPURITIES
Delete the following:
Change to read:
• Organic Impurities
Standard solution:
Sample solution
System suitability
Sample:
Suitability requirements
Resolution:
Relative standard deviation:
Analysis
Samples:
Calculate the percentage of any impurities in the portion of Ketoconazole taken:
Result = (rU/rS) × (CS/CU) × 100
Acceptance criteria:
Any individual unspecified impurity:
Total impurities:
SPECIFIC TESTS
Delete the following:
• Optical Rotation, Specific Rotation
Sample solution:
40 mg/mL in methanol
Acceptance criteria:
ADDITIONAL REQUIREMENTS
• Packaging and Storage:
Preserve in well-closed containers.
Change to read:
• USP Reference Standards Piperazine, 1-[4-[[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-4-(1-methylethyl)-, cis-; cis-1-(p-{[2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)-4-isopropylpiperazine. C26H31Cl2N5O3
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
USP38NF33 Page 4005
USP38NF33 Supplement : No. 2 Page 8127
Pharmacopeial Forum: Volume No. 40(4)
|